Simultaneous high throughput genotyping of 36 blood group systems using NGS based on probe capture technology
- PMID: 39040346
- PMCID: PMC11260914
- DOI: 10.1016/j.heliyon.2024.e33608
Simultaneous high throughput genotyping of 36 blood group systems using NGS based on probe capture technology
Abstract
Human blood group antigen has important biological functions, and transfusion of incompatible blood can cause alloimmunization and may lead to serious hemolytic reactions. Currently, serological methods are most commonly used in blood group typing. However, this technique has certain limitations and cannot fully meet the increasing demand for the identification of blood group antigens. This study describes a next-generation sequencing (NGS) technology platform based on exon and flanking region capture probes to detect full coding exon and flanking intron regions of the 36 blood group systems, providing a new high-throughput method for the identification of blood group antigens. The 871 capture probes were designed for the exon and flanking intron sequences of 36 blood group system genes, and synchronization analysis for 36 blood groups was developed. The library for NGS was tested using the MiSeq Sequencing Reagent Kit (v2, 300 cycles) by Illumina NovaSeq, and the data were analyzed by the CLC Genomics Workbench 21.0 software. A total of 199 blood specimens have been sequenced for the 41 genes from 36 blood groups. Among them, heterozygote genotypes were found in the ABO, Rh, MNS, Lewis, Duffy, Kidd, Diego, Gerbich, Dombrock, Globoside, JR, LAN, and Landsteiner-Wiene blood group systems. Only the homozygous genotype was found in the remaining 22 blood group systems. The obtained data in the NGS method shows a good correlation (99.98 %) with those of the polymerase chain reaction-sequence-based typing. An NGS technology platform for 36 blood group systems genotyping was successfully established, which has the characteristics of high accuracy, high throughput, and wide coverage.
Keywords: Blood group genotyping; Exon and flanking intron sequences; NGS; Probe capture technology.
© 2024 The Authors.
Conflict of interest statement
No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication.
Figures


Similar articles
-
Massively parallel and multiplex blood group genotyping using next-generation-sequencing.Clin Biochem. 2018 Sep;60:71-76. doi: 10.1016/j.clinbiochem.2018.07.010. Epub 2018 Aug 7. Clin Biochem. 2018. PMID: 30092181
-
The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease.Vox Sang. 2016 Nov;111(4):418-424. doi: 10.1111/vox.12432. Epub 2016 Jul 21. Vox Sang. 2016. PMID: 27442304
-
The use of next-generation sequencing for the determination of rare blood group genotypes.Transfus Med. 2019 Jun;29(3):162-168. doi: 10.1111/tme.12496. Epub 2017 Dec 18. Transfus Med. 2019. PMID: 29265667
-
Next Generation Sequencing of Red Blood Cell Antigens in Transfusion Medicine: Systematic Review and Meta-Analysis.Transfus Med Rev. 2024 Jan;38(1):150776. doi: 10.1016/j.tmrv.2023.150776. Epub 2023 Oct 7. Transfus Med Rev. 2024. PMID: 37914611
-
[The Advances and Application of ABO Blood Group Genotyping Technology --Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Apr;30(2):622-626. doi: 10.19746/j.cnki.issn.1009-2137.2022.02.050. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 35396007 Review. Chinese.
References
-
- Tsintsadze I., Akhvlediani L., Khukhunaishvili R., Koridze M., Tskvitinidze S., NakaShidze I., Dolidze K., Loria R., Nagervadze M. Specific combinations of erythrocyte group antigens in blood donors. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2020;36(2):356–360. doi: 10.1007/s12288-019-01197-4. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources